Meta‐analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority
Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1624
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 8, 2019
Authors
Publisher
Wiley